Owing to recent progress in analytical techniques, metallomics are evolving from detecting distinct trace metals in a defined state to monitor the dynamic changes in the abundance and location of trace metals in vitro and in vivo. Vascular metallomics is an emerging field that studies the role of trace metals in vasculature. This review will introduce common metallomics techniques including atomic absorption spectrometry, inductively coupled plasma-atomic emission spectrometry, inductively coupled plasma-mass spectrometry and X-ray fluorescence spectrometry with a summary table to compare these techniques. Moreover, we will summarize recent research findings that have applied these techniques to human population studies in cardiovascular diseases, with a particular emphasis on the role of copper in these diseases. In order to address the issue of interdisciplinary studies between metallomics and vascular biology, we will review the progress of efforts to understand the role of copper in neovascularization. This recent advance in the metallomics field may be a powerful tool to elucidate the signaling pathways and specific biological functions of these trace metals. Finally, we summarize the evidence to support the notion that copper is a dynamic signaling molecule. As a future direction, vascular metallomics studies may lead to the identification of targets for diagnosis and therapy in cardiovascular disease.
Introduction
The emerging field of metallomics aims to study the entirety of trace metals in a given material. Basic information about the concepts and recent advances in metallomics is available from several comprehensive reviews. [1] [2] [3] Moreover, the International Symposium on Metallomics was established to bring together scientists from the biological, chemical, environmental, clinical and measurement sciences to create a greater understanding of the role of metals and metal compounds in these systems. In addition, a new exciting international journal named Metallomics has recently been launched, and helps link the many research fields related to biometals.
Because trace metals such as zinc, iron and copper play important roles in cellular and molecular processes in biology, 4, 5 the major goal of metallomics in biology and medicine is to facilitate the dissection of the specific biological functions associated with these trace elements. Cardiovascular disease is the leading cause of death in Western countries. Growing evidence shows that trace metals, such as iron, 6-8 copper 7 and zinc, 9 appear to play an important role in the development of the disease. However, the elucidation of metals signaling pathways and their specific biological functions are still challenges and are driving forces to further extend the domain of metallomics. Thus, a new concept, vascular metallomics, is proposed here to bridge the gap between vascular biology and metallomics. The emerging field of vascular metallomics aims to address the role of trace metals in the vasculature.
Among these trace metals, copper is a redox-active metal and is an essential element that is required for normal cellular function. During the past decade, copper trafficking theory has been established and validated in several laboratories. This theory convincingly defines the regulation of uptake, distribution, sequestration and export of copper. Intracellular copper availability is extraordinarily restricted, as the intracellular milieu has a great capacity to chelate copper. 10 In the cytoplasm, copper is distributed between a number of proteins, known as copper chaperones. Copper chaperones compete with chelators and directly insert the copper cofactor into target cuproenzymes, such as cytochrome c oxidase, copper/zinc superoxide dismutase, and ATP7A, thus converting these cuproenzymes from an inactive to an active state. 11 ATP7A has attracted significant attention since its characterization as a copper P-type ATPase and copper egress pump, and the discovery that ATP7A mutation leads to human Menkes disease. We reported that ATP7A is highly expressed in human vascu lature. [12] [13] [14] These findings will also be discussed in this review.
Common metallomic technologies
The field of metallomics is comprised of a group of powerful quantitative technologies that can be used to determine the availability of metals in the complex biological environment. These technologies include atomic absorption spectrometry (AAS), X-ray fluorescence spectrometry (XRF), inductively coupled plasma-atomic emission spectrometry (ICP-AES) and inductively coupled plasma-mass spectrometry (ICP-MS). A summary of the advantages and disadvantages of each of these techniques is provided in Table 1 .
Atomic absorption spectrometry
AAS requires the analyte of interest to be in gas phase atoms, and then measures the light that is absorbed by these atoms. There are two main types of atomic absorption instruments: flame-AAS (FAAS) and graphite furnace-AAS (GFAAS). The process of drying, pyrolysis and atomization occur at the same time for FAAS, while those same processes can be separated in time when using GFAAS. This property allows GFAAS to achieve lower detection levels. In addition, FAAS is only capable of analyzing solutions while GFAAS is capable of analyzing solutions, slurries and solids.
In general, AAS is relatively inexpensive, simple to use and has high precision with low interferences. However, AAS can only detect one element at a time and does not allow for isotope analysis. Since the light source is typically a hollow-cathode lamp of the analyte of interest, its major disadvantage is that it is limited to single element detection. In order to improve the detection limits, optimizing techniques such as flow injection, 15 preconcentration/ matrix separation, 16, 17 as well as adding chemical modifiers 18 to increase the signal-to-noise ratio may improve the sensitivity of AAS.
Inductively coupled plasma
ICP is also commonly used for metal determination. This technique can be paired with atomic emission or mass spectrometric detection. ICP-AES employs an argon plasma to excite atoms and ions of analytes, and then detects the characteristic emission given off by these excited atoms and ions. The emission intensity is proportional to the concentration of the analyte of interest. The principle of ICP-MS is similar to that of ICP-AES, in which an argon plasma is used to atomize and ionize the sample, allowing for charged species to enter the mass spectrometer. The mass spectrometer separates the ions based on their mass-to-charge ratio, which also allows for the specific determination of metals and metal species. Both ICP-AES and ICP-MS are capable of simultaneous detection of more elements, but the minimum detectable concentrations for ICP-MS are lower than those of ICP-AES. ICP-AES can handle a higher dissolved solid sample than ICP-MS, but it does not have the capability for isotope analysis as does ICP-MS. Although ICP requires a higher skill level to run the instrument, it is cost-effective and the detection benefits are well worth the effort. The ICP-AES and ICP-MS methods are also suitable for analysis of solid materials applying electrothermal vaporization or laser ablation as sample introduction techniques. AAS, atomic absorption spectrometry; ICP, inductively coupled plasma; FAAS, flame-AAS; GFAAS, graphic furnace-AAS; ICP-AES, ICP-atomic emission spectrometry; ICP-MS, ICP-mass spectrometry; XRF, X-ray fluorescence spectrometry; TXRF, total reflection X-ray fluorescence spectrometry; ppm, parts per million; ppb, parts per billion; ppt, parts per trillion.
With regard to the improvement of ICP techniques, a recent metallomics study used size exclusion chromatography in conjunction with ICP-AES to identify metal-containing metalloproteins in whole blood and blood fractions. 9 This study indicates that coupling the separation technique with ICP opens a new door for the identification of metal complexes. In addition, an electrothermal vaporization technique 19 and laser ablation 20 coupled with ICP-MS have been developed to improve the signal-to-background ratio and sample application, respectively. The latter has been applied to thin slices of brain tissue to determine metal distribution. This technique is now known as elemental imaging. 21 Another hyphenated technique for ICP-MS is the use of high performance liquid chromatography (HPLC) with ICP-MS detection. HPLC is commonly used to separate different metal complexes or metal species in a complex sample matrix for determination using ICP-MS. Rabieh et al. employed the use of ion pair reverse phase HPLC to separate arsenic species in urine before detection with ICP-MS. 22 With regard to the application of ICP-MS in vascular metallomics, angiotensin II perfusion in mice has provided a valuable tool to investigate the effect of angiotensin II on the contribution of vascular diseases, particularly hypertension. 23, 24 Recently, we investigated the effect of angiotensin II on the magnesium level in the brain, heart, aorta and kidney of mice (C57BL/J) using ICP-MS. The experimental protocols were approved by the Institutional Animal Care and Use Committee at the University of Cincinnati. After infusion of angiotensin II (1000 ng kg -1 min -1 ) for 5 days, the level of magnesium was significantly decreased as compared with that infused with saline ( Figure 1 ; n = 3 for each group). Although the sample number is limited, the result of this study of mice is consistent with previous findings, indicating an association between hypertension and magnesium level. 25 Interestingly, the level of magnesium in aorta was significantly lower than other organs; whereas that in heart is markedly higher than other organs (Figure 1 ).
X-ray fluorescence spectrometry
XRF utilizes an X-ray beam to excite the electrons of an atom causing the inner shell electrons to be ejected from their shell. Electron excitation leads to vacancies in that shell which are then filled by outer shell electrons. During that process, characteristic X-rays are emitted which generates the measureable fluorescence. Because the X-ray fluorescence spectrum is unique for each element, XRF allows multi-element analysis. In addition, the measurement produces very little damage to the sample. Its minimum detectable concentrations are in the parts per million (ppm) range or lower. Recent developments of high brightness synchrotron sources and advanced X-ray focusing optics had enabled XRF microscopy with spatial resolution of 100-200 nm, allowing elemental imaging with subcellular resolution. In addition, a technique called total reflection X-ray fluorescence spectrometry (TXRF) has been developed in order to reduce the detection limits and to apply the simple internal standardization for quantitative analysis. 26 The TXRF technique was also used for determination of various elements in the fractionated part of biological materials. 27, 28 TXRF is based on energy dispersive X-ray fluorescence and offers sub-ppm detection levels for a variety of sample types.
With regard to the application of XRF in vascular metallomics, in our laboratories we use THP-1 cells as a model cell to study the role of ATP7A and copper egress in macrophage. Synchrotron-based XRF microscopy provides the opportunity to detect the spatial copper distribution and concentration in a single cell. Figure 2 illustrates the qualitative spatial distribution and concentration of metal elements including phosphorus, chlorine, potassium, calcium, zinc and copper in THP-1 cells after treatment with copper for a brief period. Moreover, XRF also shows a great potential to investigate the role of metal in vivo. Figure 3 illustrates that XRF can detect small accumulations of metals such as iron, copper and zinc in the arterial walls of a murine atherosclerotic model. Note that this experiment was performed using the same cohort of mice as a micro-CT study. 29
Copper levels in human cardiovascular disease
Growing evidence of the importance of metals in biological processes makes detection of metals in tissues and cells very critical. Population studies in human disease have applied several different metallomics techniques in order to find answers to problems that plague mankind. [30] [31] [32] [33] The instrument was equipped with a microconcentric nebulizer made by Glass Expansion (Pocasset, MA, USA), a Scott double channel spray chamber (2°C), a shielded torch with a sampling depth of 7 mm, nickel sampling and skimmer cones, a CE lens stack, an octopole collision/reaction cell with hydrogen gas (Matheson Gas Products, Parisppany, NJ, USA) pressurization (purity of 99.999%) at a flow rate of 4 ml min -1 , a quadruple mass analyzer with a dwell time of 100 ms per isotope and an electron multiplier for detection. Instrumental parameters were as follows: forward power, 1500 W; plasma gas flow rate, 15.0 l min -1 ; carrier gas flow rate, 0.99 l min -1 ; makeup gas flow rate, 0.14 l min -1 ; monitored isotope, 24 Mg. Samples were repeated three times and averaged for statistic error. The sample values were normalized to the total protein content.
summarizes recent human population studies of cardiovascular diseases that have applied classic metallomics approaches, with a particular emphasis on the role of copper in these diseases. In addition, a recent review by Brewer 7 provides additional prospective in this topic.
An imbalance of trace elements and metals appears to be a possible cause of coronary heart disease (CHD). Manthey et al. investigated the concentrations of several critical metals, including magnesium, chromium, copper, manganese, selenium and zinc in serum from three different groups of patients. Group 1 patients had no signs of CHD, group 2 patients showed signs of moderate CHD and group 3 patients had severe CHD. 34 The authors used a combination of analytical techniques that included FAAS for the detection of magnesium and zinc, GFAAS for the detection of chromium, manganese, copper, cadmium and lead, and neutron activation analysis for the detection of selenium. They established that there is a relationship between magnesium, copper and manganese serum concentrations and there is a significant difference between group 1 and group 3 patients. Most of the metals detected were in the ppm to ppb (parts per billion) range.
Copper and selenium concentrations in human serum was also studied by Salonen and colleagues. 35 Using FAAS for the detection of copper and GFAAS for the detection of selenium, they reported concentrations in the ppb range. In their study, they examined the relationship between serum copper and selenium concentrations, and low density lipoprotein cholesterol concentration and intima-media thickness. They determined that if there was a high copper concentration in the serum, then the other factors examined in the study would cause a variation in the intima-media thickness. Salonen and co-workers reported values as low as 78 ppb and 712 ppb for selenium and copper, respectively.
Since copper plays such an active role in oxidation/ reduction reactions within the body, the levels of serum copper from patients who have died from CHD were studied by Ford. 36 FAAS was used to measure the amount of copper in the sera of patients who participated in the Second National Health and Nutrition Examination Survey. Copper concentrations as low as 370 ppb were reported for this study. It is also demonstrated that there is a strong correlation between serum copper concentration and CHD mortality.
The copper/zinc ratio in the body has also been studied as a potential cause of oxidative stress that characterize Detection of iron, copper and zinc in arterial walls using X-ray fluorescence spectrometry (XRF). XRF was performed using the atherosclerotic aorta of a murine model (ApoE -/-LDLR -/double knockout mice). An incident photon energy of 13.7 keV was chosen to excite the elements. Single 6-µm thick sections were cut from formalin-fixed and paraffin-embedded tissue blocks and mounted on silicon nitride membranes (Silson, Northampton, England) with a nominal field-of-view of 4 mm 2 . An X-ray beam, focused to a spot size of 0.5 µm, was used to raster-scan the 6-µm thick section. Spectral analysis of the excited X-ray fluorescence spectrum at each raster pixel then provided spatial images for each element. Under this condition, copper, iron and zinc were readily detected. Note that the XRF image itself just describes the distribution but not concentration of metal. In a separate format of XRF, element concentrations were determined using calibrated thin-film standards of the elements of interest. Among them, iron is the one that is detected at the highest level, followed by zinc and then copper. GFAAS, graphic furnace-AAS; AAS, atomic absorption spectrometry; FAAS, flame-AAS; TXRF, total reflection X-ray fluorescence spectrometry; ICP-MS, inductively coupled plasma mass spectrometry.
age-related degenerative diseases. Mezzetti et al. investigated the copper/zinc ratio in three different groups of patients. 37 Group 1 consisted of patients who were healthy and above the age of 80 years, while group 2 consisted of patients who had an age-related degenerative disease such as a stroke, Parkinson's or Alzheimer's and who were also above the age of 80 years. Group 3 patients were in the range of 20-70 years of age and healthy. Copper and zinc concentrations in serum were analyzed using FAAS and the values reported were as low as 1.2 ppm. It was concluded that the copper/zinc ratio does play an active role in oxidative stress modulation.
All of these studies employed a type of AAS in order to analyze trace metals, such as copper, selenium and zinc. The concentrations of the metals in serum were mainly in the high ppb to low ppm range. Since most of the studies discussed in this section investigated more than one trace metal, and AAS can only be used for single metal analysis, there should have been at least two sets of each sample to enable the measurement of both metals. Therefore, XRF and ICP, which both allow for multi-element detection, appear to be better options for these studies if the equipment is available.
XRF offers multi-element detection capabilities as well as the ability to handle various sample matrices. Mansoor and co-workers used TXRF in order to investigate the correlation between copper and other nutritional elements and plasma total homocysteine levels in patients with peripheral vascular disease (PVD). 38 By measuring the intensity of characteristic fluorescence X-rays of copper, they were able to obtain a concentration of 20.3 µg/g copper in plasma. These results indicate a strong correlation between copper concentration and plasma total homocysteine levels in PVD patients.
Compared to XRF, ICP-MS can offer faster analysis times with lower limits of detection. Stadler et al. investigated the presence of iron and copper in atherosclerotic plaques through the use of ICP-MS. In this study, diseased human artery samples and healthy artery samples were obtained from patients undergoing surgery. The tissue samples were digested in acid and analyzed with ICP-MS to determine the total metal concentration in three different sample types. The values obtained were in the nmol/mg range. Using ICP-MS, the authors were able to detect and quantify a very low level of iron and copper in three different tissue samples. They could positively conclude that there is a connection between iron and copper concentration and heart disease. 39 Not only did ICP-MS offer low detection limits, the technique also allows for the simultaneous detection of iron and copper, so the limited amount of patient samples are acquired.
Copper in angiogenesis
As previously mentioned, the major goal of metallomics is to dissect the specific biological effects of these trace elements. While studies have found that the total copper content in the samples from the patients with heart disease appears to be increased, the elucidation of the copper-dependent mechanism remains a challenge and this challenge extends the domain of metallomics. Indeed, classic total element determination has evolved to include a combination of metal analytical techniques with various molecular approaches. For example, the concept of metallomics has been introduced in the field of epigenetics to address the increasing evidence that trace metals may be involved in DNA methylation, modification of histone proteins and RNA interference (see review by Wrobel et al. 3 ). Additional information about the potential role of copper in cardiovascular disease in animal models has been summarized elegantly in a recent review by Saari. 40 Neovascularization refers to the formation of new blood vessels. This important biological process is known to be sensitive to copper levels. 41, 42 Lowering copper levels appears to be a potentially effective antiangiogenic approach to cancer treatment (see review 43 ). Recent developments in X-ray fluorescence microscopy (XFM) analysis provide an exciting resource for highly sensitive visualization and quantitation of metals in biological samples (see review by Fahrni 44 ). Using this technique, Finney et al. 45 recently observed that cellular copper traffics from intracellular compartments to the tips of nascent endothelial cell filopodia and extracellular space in response to the angiogenic stimulus, vascular endothelial growth factor (VEGF). This finding indicates that copper egress is induced by VEGF, and this dynamic developmental process is required for endothelial tube formation. Since we previously identified that ATP7A, a key regulator of copper egress, is abundant in vascular endothelial cells, 12 it is reasonable to speculate that VEGF-induced copper egress from endothelial cells is mediated by ATP7A. Moreover, the recruitment of monocytes/macrophages by VEGF, through VEGF receptor (VEGFR) 1, is an early and essential step in an immune amplification cascade that leads to the inflammatory response of angiogenesis. 46, 47 Activation of VEGFR1 results in epithelial to mesen chymal transition, which is linked to increased invasion and migration of tumor cells. [48] [49] [50] We have reported 14 that ATP7A expression was increased in a human monocytic cell line after exposure to PMA, a potent promoter of neovascularization and cancer. 51 Our data also indicated that VEGF receptor (VEGFR) 1 expression is regulated by ATP7A-mediated copper egress. This finding further supports a role of copper egress in neovascularization. As future directions, it would be interesting to examine the participation of the copper trafficking pathway other than ATP7A in neovascularization. To gain more information about the molecules involved into the copper trafficking pathway, recent reviews by Prohaska 52 and Lutsenko et al. 53 are very helpful.
Copper as a dynamic signaling molecule
Accumulating evidence indicates that copper is a signaling molecule 54 that can alter cellular functions through at least four different mechanisms. First, copper facilitates the generation of free radicals, which, in turn, catalyze the oxidation of biomolecules such as lipids, proteins, and nucleic acids (reviewed by Kehrer et al. 55 ). Copper overload has long been hypothesized to result from the redox cycling Haber-Weiss reaction in which cuprous ions react with H 2 O 2 to form reactive oxygen species. However, this effect is believed to be minimal under a pathophysiological condition. 56 The intracellular environment has a great capacity to chelate copper, so free copper is extraordinarily restricted in cells. 10 Thus, as a future direction for metallomics, it is important to finely tune the pathological concentrations of copper that are associated with its detrimental effects. Second, copper may regulate gene expression through binding to copper-responsive regulatory elements of gene promoters. For example, overexpression of ATP7A has been shown to significantly reduce β-amyloid precursor protein (APP) levels and down-regulate APP mRNA expression, presumably through this mechanism. 57 Sen et al. reported that copper regulates VEGF expression and neovascularization related to wound healing. 58 Moreover, our data showed that inhibition of ATP7A expression resulted in a marked decrease in VEGFR1 expression in macrophages. 14 Third, copper can regulate protein-protein interactions. In a previous in vitro study, we reported that copper increased the interaction between ATP7A and ecSOD, and that a copper chelator (bathocuproine disulfonate) attenuated this interaction. 12 Finally, copper directly binds to and regulates proteins containing cysteine, histidine or glutamic acid residues, including enzymes involved in antioxidant defense (SOD1 and ecSOD), cellular respiration (cytochrome c oxidase), catecholamine synthesis (dopamine-β-hydroxylase), pigmentation (tyrosinase) and integration of the vascular wall (lysyl oxidase). Note that the antioxidative effect of copper is, at least in part, related to its role in the maintenance of the full activity of several antioxidants such as SOD1 and ecSOD. The basic information about the detailed mechanisms by which copper is inserted into SOD1 and ecSOD is available from a recent review by Culotta. 59 As a future direction, it is also important to define the physiological range of tissue copper that is associated with the beneficial effects of copper using metallomics-based approaches.
